Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VRC01 during ATI in early acute HIV (RV 397)
NCT02664415Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Aug 2016
- Primary completion
- Aug 2017
- Modality
- Anti-infectious Disease mAbs
- Countries
- 1
01
Overview
A Phase 2 trial of VRC01 in human immunodeficiency virus infection (HIV), sponsored by National Institute of Allergy and Infectious Diseases. Started Aug 2016; status: completed.
02
Drugs
VRC01
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02664415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02664415.